Total Funding
5
6
Total FundingConvertible Note raised
Growth Score 5 in past quarter
-3 pts
Heat Score 6 in past quarter
-52 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
372105
NoPricks: Needle-free insulin patches, new hair growth product, potential vaccine patches.
- Roger S. Mazze: Chairman
Stephen Hsu: Founder, CEO & CSO
About the Company
Platform biotech from University of Florida with needle-free transdermal patch delivery of large molecules. So far insulin, IGF-1, and hGH- 100x bigger than nicotine molecules delivered successfully to boost patient compliance and access. Initial $20B/year market with industry collaboration model that generates revenue before product launch.
